Ausencia de asociación entre el genotipo de la apolipoproteína E y la respuesta al tratamiento con estatinas en los pacientes con episodios isquémicos agudos-Reference-Cited by-同舟云学术

Ausencia de asociación entre el genotipo de la apolipoproteína E y la respuesta al tratamiento con estatinas en los pacientes con episodios isquémicos agudos

Published:2008-03 Issue:11 Volume:130 Page:401-404
ISSN:0025-7753
Container-title:Medicina Clínica
language:es
Short-container-title:Medicina Clínica

Author:

Oliveira Sousa Marinez,Corbella Emilio,Alía Pedro,Cámara Jordi,José Castro María,Pintó Xavier,Ángel Navarro Miguel

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Molecular mechanisms involved in atherosclerosis;Soufi;Herz,2002

2. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology;Mahley;Science,1988

3. Characterization and mapping to chromosome 19 of the human apolipoprotein E gene;Das;J Biol Chem,1985

4. Apolipoprotein E polymorphism in health and disease;Utermann;Am Heart J,1987

5. Apolipoprotein E polymorphism and cardiovascular disease: A huge review;Eichener;Am J Epidemiol,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ApoA5-1131T→C polymorphism and its effect on triglyceride level in type 2 diabetes patients with nephropathy;Comparative Clinical Pathology;2012-08-16

2. Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events;Drug Metabolism and Drug Interactions;2011-01-01

3. Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents;Molecular Biology Reports;2010-12-04

4. Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?;Pharmacogenomics;2010-07

5. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders;Neurochemistry International;2010-01